META · Meta Platforms, Inc. · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-10-19 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12. |
Class A Common Stock
(I)
|
408 |
| 2026-10-19 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person's spouse, manager of Reinhold D LLC. |
Class A Common Stock
(I)
|
82 |
| 2026-10-19 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person, manager of Olivan D LLC. |
Class A Common Stock
(I)
|
82 |
| 2026-10-19 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. |
Class A Common Stock
|
946 |
| 2026-10-19 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC. |
Class A Common Stock
(I)
|
57 |
| 2026-10-12 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person, manager of Olivan D LLC. |
Class A Common Stock
(I)
|
82 |
| 2026-10-12 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. |
Class A Common Stock
|
946 |
| 2026-10-12 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12. |
Class A Common Stock
(I)
|
408 |
| 2026-10-12 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person's spouse, manager of Reinhold D LLC. |
Class A Common Stock
(I)
|
82 |
| 2026-10-12 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC. |
Class A Common Stock
(I)
|
57 |
| 2026-10-05 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12. |
Class A Common Stock
(I)
|
408 |
| 2026-10-05 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. |
Class A Common Stock
|
946 |
| 2026-10-05 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person's spouse, manager of Reinhold D LLC. |
Class A Common Stock
(I)
|
82 |
| 2026-10-05 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC. |
Class A Common Stock
(I)
|
57 |
| 2026-10-05 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person, manager of Olivan D LLC. |
Class A Common Stock
(I)
|
82 |
| 2026-09-28 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12. |
Class A Common Stock
(I)
|
408 |
| 2026-09-28 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person, manager of Olivan D LLC. |
Class A Common Stock
(I)
|
82 |
| 2026-09-28 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. |
Class A Common Stock
|
946 |
| 2026-09-28 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person's spouse, manager of Reinhold D LLC. |
Class A Common Stock
(I)
|
82 |
| 2026-09-28 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC. |
Class A Common Stock
(I)
|
57 |
| 2026-09-24 | Zuckerberg Mark |
Director, COB and CEO, 10% Owner |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.045 to $779.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares. |
Class A Common Stock
(I)
|
2,146 |
| 2026-09-24 | Zuckerberg Mark |
Director, COB and CEO, 10% Owner |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.08 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI. |
Class A Common Stock
(I)
|
600 |
| 2026-09-24 | Zuckerberg Mark |
Director, COB and CEO, 10% Owner |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.00 to $776.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI. |
Class A Common Stock
(I)
|
2,516 |
| 2026-09-24 | Zuckerberg Mark |
Director, COB and CEO, 10% Owner |
Other↑
Filing footnotes — Class A Common Stock (Indirect)
Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI. |
Class A Common Stock
(I)
|
17,140 |
| 2026-09-24 | Zuckerberg Mark |
Director, COB and CEO, 10% Owner |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $776.03 to $777.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares. |
Class A Common Stock
(I)
|
1,769 |
| 2026-09-24 | Zuckerberg Mark |
Director, COB and CEO, 10% Owner |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $778.03 to $778.99 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI. |
Class A Common Stock
(I)
|
4,324 |
| 2026-09-24 | Zuckerberg Mark |
Director, COB and CEO, 10% Owner |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.04 to $778.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares. |
Class A Common Stock
(I)
|
4,810 |
| 2026-09-24 | Zuckerberg Mark |
Director, COB and CEO, 10% Owner |
Other↓
Filing footnotes — Class B Common Stock (Indirect)
The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date. Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI. |
Class B Common Stock
(I)
|
17,140 |
| 2026-09-24 | Zuckerberg Mark |
Director, COB and CEO, 10% Owner |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares. |
Class A Common Stock
(I)
|
1,133 |
| 2026-09-24 | Zuckerberg Mark |
Director, COB and CEO, 10% Owner |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $777.02 to $778.005 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI. |
Class A Common Stock
(I)
|
7,607 |
| 2026-09-24 | Zuckerberg Mark |
Director, COB and CEO, 10% Owner |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected by Chan Zuckerberg Biohub, Inc. ("CZ Biohub") pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $779.07 to $779.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by CZ Biohub. The reporting person is deemed to have sole voting and investment power over the shares held by CZ Biohub, but has no pecuniary interest in these shares. |
Class A Common Stock
(I)
|
476 |
| 2026-09-24 | Zuckerberg Mark |
Director, COB and CEO, 10% Owner |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on January 31, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $775.00 to $775.965 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI. |
Class A Common Stock
(I)
|
2,093 |
| 2026-09-21 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025 |
Class A Common Stock
|
946 |
| 2026-09-21 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025 Shares held of record by the reporting person's spouse, manager of Reinhold D LLC. |
Class A Common Stock
(I)
|
82 |
| 2026-09-21 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025 Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC. |
Class A Common Stock
(I)
|
57 |
| 2026-09-21 | Cox Christopher K |
Chief Product Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $700.00 to $700.92 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust. |
Class A Common Stock
(I)
|
20,000 |
| 2026-09-21 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025 Shares held of record by the reporting person, manager of Olivan D LLC. |
Class A Common Stock
(I)
|
82 |
| 2026-09-21 | Cox Christopher K |
Chief Product Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $725.00 to $725.06 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust. |
Class A Common Stock
(I)
|
20,000 |
| 2026-09-21 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025 Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12. |
Class A Common Stock
(I)
|
408 |
| 2026-09-15 | Cox Christopher K |
Chief Product Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $675.005 to $675.35 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust. |
Class A Common Stock
(I)
|
20,000 |
| 2026-09-14 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC. |
Class A Common Stock
(I)
|
57 |
| 2026-09-14 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person's spouse, manager of Reinhold D LLC. |
Class A Common Stock
(I)
|
82 |
| 2026-09-14 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person, manager of Olivan D LLC. |
Class A Common Stock
(I)
|
82 |
| 2026-09-14 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. |
Class A Common Stock
|
946 |
| 2026-09-14 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12. |
Class A Common Stock
(I)
|
408 |
| 2026-09-09 | Cox Christopher K |
Chief Product Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $650.00 to $650.93 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust. |
Class A Common Stock
(I)
|
18,578 |
| 2026-09-09 | Cox Christopher K |
Chief Product Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sales reported were effected pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $651.015 to $651.26 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust. |
Class A Common Stock
(I)
|
1,422 |
| 2026-09-08 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Indirect)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $618.64 to $619.41 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12. |
Class A Common Stock
(I)
|
157 |
| 2026-09-08 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $617.89 to $618.53 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
529 |
| 2026-09-08 | Olivan Javier |
Chief Operating Officer |
Sell↓
Filing footnotes — Class A Common Stock (Direct)
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $619.98 to $620.78 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Class A Common Stock
|
78 |